Snyder Capital Management L P Purchases 69,835 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Snyder Capital Management L P grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,194,802 shares of the company's stock after buying an additional 69,835 shares during the period. Henry Schein accounts for approximately 1.7% of Snyder Capital Management L P's portfolio, making the stock its 21st largest position. Snyder Capital Management L P owned about 0.96% of Henry Schein worth $82,680,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. Versant Capital Management Inc raised its holdings in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after purchasing an additional 335 shares in the last quarter. Venturi Wealth Management LLC boosted its position in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC grew its position in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC increased its stake in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. Finally, City State Bank acquired a new position in Henry Schein in the fourth quarter valued at $55,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on HSIC shares. Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Finally, Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $80.20.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Down 2.3 %

NASDAQ HSIC traded down $1.51 on Wednesday, hitting $64.65. 292,108 shares of the company were exchanged, compared to its average volume of 1,616,308. The company's 50 day moving average price is $68.73 and its 200-day moving average price is $71.72. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market capitalization of $7.92 billion, a P/E ratio of 26.61, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.